The Myoglobin/Ck-Mb/Troponin I Combo Rapid Test is an essential diagnostic tool for the early detection of myocardial infarction (MI). This qualitative immunological test is designed to detect the presence of Myoglobin, CK-MB and Troponin I (cTnl) in whole blood, serum or plasma, providing fast and reliable results for healthcare professionals.

Features of the Combo Rapid Test

• Professional use: For in vitro diagnostic use only.


• Sample type: Can be used with whole blood, serum or plasma.


• Rapid results: Detection of Myoglobin within 2-4 hours, CK-MB within 3-8 hours and Troponin I within 4-6 hours after symptom onset.


• Detection window: Troponin I remains elevated for up to 6-10 days, offering a greater opportunity for diagnosis.

Test Components

The test is based on the detection of three key biomarkers:

• Myoglobin (MYO): A protein rapidly released into the blood in the event of muscle damage, useful for early diagnosis.


• CK-MB: A heart muscle-specific enzyme whose release into the blood indicates cardiac damage.


• Troponin I (cTnl): A cardiac protein that provides crucial information about heart health and remains elevated longer than the other markers.

How the Test Works

The Combo Rapid Test uses a membrane pre-coated with specific antibodies. During the test:

1. The whole blood, serum or plasma sample is applied to the membrane.


2. The antibody-coated particles react with the biomarkers present in the sample.


3. The compound migrates chromatographically across the membrane, generating colored lines that indicate the presence or absence of the markers.

The presence of a colored line in the test area indicates a positive result, while the absence of this line indicates a negative result. A procedural control ensures that the test has been performed correctly, always showing a colored line in the control area.

Advantages of the Myoglobin/Ck-Mb/Troponin I Rapid Test

• Timely diagnosis: Allows rapid identification of a possible myocardial infarction.


• Ease of use: Simple and quick test, suitable for clinical use.


• Reliability: High sensitivity and specificity in the detection of cardiac biomarkers.

Conclusion

The Myoglobin/Ck-Mb/Troponin I Combo Rapid Test represents an effective solution for healthcare professionals in the diagnosis of critical cardiac conditions. With its ability to provide fast and accurate results, it is a valuable ally in managing heart health.